Snowden Capital Advisors LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1903055
New York, NY
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,212,840
+$141,141 QoQ
Shares Held
2,864
+6.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Snowden Capital Advisors LLC holds $12,608,129 across 22 Biotechnology names. REGN ranks #1 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,864 | $2,212,840 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,833 | $1,711,587 | |
| 3 | ARGX |
Argenx SE
|
2,117 | $1,545,939 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,383 | $1,247,429 | |
| 5 | INSM |
INSMED Inc
|
7,571 | $1,238,009 | |
| 6 | MRNA |
Moderna, Inc.
|
12,722 | $646,277 | |
| 7 | IDYA |
IDEAYA Biosciences, Inc.
|
19,231 | $640,776 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
1,197 | $355,473 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,212,840 | 2,864 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,071,699 | 2,684 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,284,224 | 2,284 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $901,950 | 1,718 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,224,698 | 1,931 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,151,837 | 1,617 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,586,321 | 1,509 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,774,138 | 1,688 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,771,944 | 1,841 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,020,572 | 1,162 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $926,652 | 1,126 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $861,529 | 1,199 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $925,200 | 1,126 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $984,112 | 1,364 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,004,372 | 1,458 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $960,586 | 1,625 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,350,744 | 1,934 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $479,323 | 759 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,095,375 | 1,810 | Shares | Sole | 2024-02-06 | |
| 2021-06-30 | $1,004,813 | 1,799 | Shares | Sole | 2024-01-08 | |
| 2021-03-31 | $702,612 | 1,485 | Shares | Sole | 2024-01-08 | |
| 2020-12-31 | $355,085 | 735 | Shares | Sole | 2024-01-08 | |
| 2020-09-30 | $287,167 | 513 | Shares | Sole | 2024-01-08 | |
| 2020-06-30 | $314,319 | 504 | Shares | Sole | 2024-01-08 | |
| 2020-03-31 | $256,840 | 526 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||